Chronic central versus systemic blockade of AT1 receptors and cardiac dysfunction in rats post-myocardial infarction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 3, 2009, Pages

  Huang, Bing S ^a   Ahmad, Monir ^a   Tan, Junhui ^a   Leenen, Frans H H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

ANG II type 1; Brain; Cardiac remodeling; Echocardiography; Losartan; Millar catheter

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NUCLEUS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRESSLER SYNDROME; DRUG RECEPTOR BINDING; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PEAK SYSTOLIC PRESSURE; HEART WORK; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; WISTAR RAT;

ADMINISTRATION, ORAL; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ECHOCARDIOGRAPHY; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SUBCUTANEOUS; LOSARTAN; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 69249141072     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00317.2009     Document Type: Article

References (32)

1. Ahmad M, White R, Tan J, Huang BS, Leenen FHH. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction. J Cardiovasc Pharmacol 51: 565-572, 2008.
2. Aylward PE, McRitchie RJ, West MJ, Chalmers JP. Relative roles of vagal and sympathetic effector mechanisms in the baroreflex control of myocardial contractility in conscious rabbits. Pflügers Arch 403: 21-27, 1985.
3. Bodineau L, Frugière A, Marc Y, Inguimbert N, Fassot C, Balavoine F, Roques B, Llorens-Cortes C. Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension. Hypertension 51: 1318-1325, 2008.
4. Bove CM, Yang Z, Gilson WD, Epstein FH, French BA, Berr SS, Bishop SP, Matsubara H, Carey RM, Kramer CM. Nitric oxide mediates benefits of angiotensin II type 2 receptor overexpression during post-infarct remodeling. Hypertension 43: 680-685, 2004.
5. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling. J Am Coll Cardiol 35: 569-582, 2000.
6. Huang BS, Ahmad M, Tan J, Leenen FHH. Sympathetic hyperactivity and cardiac dysfunction post-MI: different impact of specific CNS versus general AT1 receptor blockade. J Mol Cell Cardiol 43: 479-486, 2007.
7. Kaur K, Sharma AK, Singal PK. Significance of changes in TNF- and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am J Physiol Heart Circ Physiol 291: H106-H113, 2006.
8. Lacour C, Roccon A, Galindo G, Canals F, Hogie M, Segondy D, Briand D, Roque C, Herbert JM, Nisato D. Effects of differential blockade of the renin-angiotensin system in postinfarcted rats. Fundam Clin Pharmacol 18: 299-307, 2004.
9. Lal A, Veinot JP, Ganten D, Leenen FHH. Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen. J Mol Cell Cardiol 39: 521-529, 2005.
10. Leenen FHH. Brain mechanisms contributing to sympathetic hyperactivity and heart failure. Circ Res 101: 221-223, 2007.
11. Lindley TE, Doobay MF, Sharma RV, Davisson RL. Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure. Circ Res 94: 402-409, 2004.
12. Lindley TE, Infanger DW, Rishniw M, Zhou Y, Doobay MR, Sharma RV, Davisson RL. Scavenging superoxide selectively in mouse forebrain is associated with improved cardiac function and survival following myocardial infarction. Am J Physiol Regul Integr Comp Physiol 296: R1-R8, 2009.
13. Martinez LA, Villalobos-Molina R. Early and chronic captopril or losartan therapy reduces infarct size and avoids congestive heart failure after myocardial infarction in rats. Arch Med Res 34: 357-361, 2003.
14. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodeling. Lancet 367: 356-367, 2006.
15. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates (4th ed.). San Diego, CA: Acadamic Press, 1998.
16. Pourdjabbar A, Parker TG, Nguyen QT, Desjardins JF, Lapointe N, Tsoporis JN, Rouleau JL. Effects of pre-, peri-, and postmyocardial infarction treatment with losartan in rats: effect of dose on survival, ventricular arrhythmias, function, and remodeling. Am J Physiol Heart Circ Physiol 288: H1997-H2005, 2005.
17. Remme WJ, Riegger G, Hildebrandt P, Komajda M, Jaarsma W, Bobbio M, Soler-Soler J, Scherhag A, Lutiger B, Rydén L. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN). Cardiovasc Drugs Ther 18: 57-66, 2004.
18. Rodríguez-Martínez M, Sawin LL, DiBona GF. Arterial and cardiopulmonary baroreflex control of renal nerve activity in cirrhosis. Am J Physiol Regul Integr Comp Physiol 268: R117-R129, 1995.
19. + exchanger and LV dysfunction after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 277: H610-H616, 1999.
20. Schefe JH, Unger T, Funke-Kaiser H. PLZF and the (pro)renin receptor. J Mol Med 86: 623-627, 2008.
21. 1 receptor blockade after myocardial infarct on myocardial fibrosis, stiffness, and contractility. Am J Physiol Heart Circ Physiol 276: H873-H880, 1999.
22. van Kats JP, Duncker DJ, Haitsma DB, Schuijt MP, Niebuur R, Stubenitsky R, Boomsma F, Schalekamp MA, Verdouw PD, Danser AH. Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II. Circulation 102: 1556-1563, 2000.
23. Wang H, Huang BS, Ganten D, Leenen FHH. Prevention of sympathetic and cardiac dysfunction after myocardial infarction in transgenic rats deficient in brain angiotensinogen. Circ Res 94: 843-849, 2004.
24. 1 receptor blockers. J Cardiovascular Pharmacol 41: 593-599, 2003.
25. White M, Rouleau JL, Afzal R, Floras J, Yusuf S, McKelvie RS. Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker. Ther Adv Cardiovasc Dis 3: 113-121, 2009.
26. Wright JW, Tamura-Myers E, Wlison WJ, Roques BP, Llorens-Cortes C. Conversion of brain angiotensin II to III is critical for pressor response in rats. Am J Physiol Regul Integr Comp Physiol 284: R725-R733, 2003.
27. Yan X, Price RL, Nakayama M, Ito K, Schuldt AJ, Manning WJ, Sanbe A, Borg TK, Robbins J, Lorell BH. Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice. Am J Physiol Heart Circ Physiol 285: H2179-H2187, 2003.
28. Yu Y, Wei SG, Zhang ZH, Gomez-Sanchez E, Weiss RM, Felder RB. Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure? Hypertension 51: 727-733, 2008.
29. Zhang W, Huang BS, Leenen FHH. Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction. Am J Physiol Heart Circ Physiol 276: H1608-H1615, 1999.
30. Zhang ZH, Francis J, Weiss RM, Felder RB. The renin-angiotensin- aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure. Am J Physiol Heart Circ Physiol 283: H423-H433, 2002.
31. 1 receptor mRNA antisense normalizes enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure. Am J Physiol Heart Circ Physiol 287: H1828-H1835, 2004.
32. Zucker IH. Novel mechanisms of sympathetic regulation in chronic heart failure. Hypertension 48: 1005-1011, 2006.